MedPath

Ayurvedic Management of Tamakasvasa(Bronchial Asthma)

Phase 3
Conditions
Health Condition 1: null- mild to moderate persistent bronchial asthma
Registration Number
CTRI/2015/09/006158
Lead Sponsor
j s ayurveda college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

(1)Patient between the ages of 20 to 60 years.

(2)Uncomplicated cases with classical picture of Tamaka svasa, irrespective of demographical division.

(3)Patients having intermittent, mild persistence, or moderate persistant type of asthma severity will be selected for the study. Severity of Asthma will be assessed according to the gradation for asthma severity assessment adopting from primary care respiratory journal 17 (3): 138-147 (September 2008 by Yawn BP et. Al.).

Exclusion Criteria

(1)Patient suffering from disease like known case of HTN, Cancer, AIDS, LVH, IHD, Tuberculosis and other systemic disorder which leads to the fatal condition of the patient.

(2)Patients having HbA1c above 7.5 of diabetes mellitus.

(3)Patients who have taken medication of corticosteroids, psycho pharmacological drugs within last 6 months.

(4)Patients having Status asthmaticus and acute severe exacerbation exacerbation of asthma or severe persistent asthma will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak Expiratory Flow Rate PEFR <br/ ><br>Forced Expiratory Volume In one Second FEV1Timepoint: PEFR and FEV1 wil be meassered at every 7 days during treatment period
Secondary Outcome Measures
NameTimeMethod
breathlessnes <br/ ><br>coughingTimepoint: every week during treatment period
© Copyright 2025. All Rights Reserved by MedPath